<<<<<,,As of November 2, 2005, the Company had 36,240,437 issued and outstanding shares of common stock.
As of November 3, 2006, the Company had 40,280,615 outstanding shares of common stock.
The computation of Diluted EPS does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings. As of September 30, 2005 and 2004, the Company had approximately 11,379,557 and 16,177,872 of anti-dilutive securities, including options, warrants and equity instruments related to convertible notes payable.
The computation of Diluted EPS does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings. As of September 30, 2006 and 2005, the Company had approximately 14,406,146 and 11,379,557 respectively, of anti-dilutive securities, including options, warrants and equity instruments related to convertible notes payable. >>>>>>>>>
*********************************************************************************************************
The above is from the filings of 2005 and 2006 and several pieces of information can be garnered from it.
First you can easily see the number of options/warrants exercised/granted from Nov 2004 to Nov 2005.
16,177,872 - 11,379,557 = 4,798,315
The number of net warrants/options exercised/granted from Nov 2005 to Nov 2006
14,406,146 - 11,379,557 = 3,026,589
The S/O on Nov 2005 was 36,240,437 + 11,379,557 options and warrants = 47,619,994 F/D
The S/O on Nov 2006 was 40,280,615 + 14,406,146 options and warrants = 54,686,761 F/D